Samuraciclib trihydrochloride

• Target:

  Others

• Related Pathways:

  Others

• Bioactivity:

  Samuraciclib (CT7001) trihydrochloride is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib trihydrochloride displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib trihydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 ?M. Samuraciclib trihydrochloride has anti-tumor effects[1][2].

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C